LncRNA ZEB1-AS1: A New Player in Epigenetic Control of Cardiac Hypertrophy. [PDF]
Giugni FR.
europepmc +1 more source
Conflicting Clues in Severe LV Hypertrophy: An Unusual Presentation of ATTR Amyloidosis. [PDF]
Fernandes ASN, Faria J, Vieira CF.
europepmc +1 more source
Danon Disease: Understanding the Role of LAMP2 Variants in Cardiomyopathy and Multisystemic Involvement. [PDF]
Ribeiro GNP +7 more
europepmc +1 more source
Prevalence of Hypertrophic Cardiomyopathy in Brazil: What is Our Reality? [PDF]
Ayub-Ferreira SM.
europepmc +1 more source
Late-Onset Fabry Disease: Diagnostic Challenges and Clinical Evolution. [PDF]
Mejía HPG +7 more
europepmc +1 more source
PRKAG2 Cardiomyopathy: A Case-Control Study on the Diagnostic Yield Of Histopathology and Ultrastructural Analysis from Endomyocardial Biopsy. [PDF]
Honorato-Sampaio K +11 more
europepmc +1 more source
Fernanda Maria de Figueiredo +1 more
doaj
Knockdown of the Long Noncoding RNA ZEB1-AS1 Accelerates Cardiac Hypertrophy via the miR-186-5p/HDAC2 Pathway. [PDF]
Cao B, Liu Q, Zhang X, Wang Y.
europepmc +1 more source
Position Statement on Multimodal Cardiac Imaging in Patients with Systemic Diseases - 2026. [PDF]
Hotta VT +27 more
europepmc +1 more source
mRNA, miRNA, lncRNA, ceRNA: The Future of Cardiovascular Research? [PDF]
Mota GAF +4 more
europepmc +1 more source

